Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 103.83 Bil Enterprise Value: 104.53 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 24, 2021 / 04:40PM GMT
Release Date Price: R$443
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Great. Okay. Thank you, guys, for joining us. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Karleen Oberton, the CFO of Hologic; and Mike Watts from the IR team.

It will be a question-and-answer session. So if you have any questions, feel free to send me an e-mail. I'll try to get those asked as we go.

But again, thank you, guys, for being here.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

And Karleen, maybe not surprisingly, to start on the COVID side. Obviously, cases and testing have been quite elevated. They're starting to come down at least a little bit here in the U.S. over the past month.

You guys are increasing capacity as we go. The volumes have been obviously pretty incredible over the past few quarters. Maybe just update us in terms of the general supply-demand dynamic for you guys as we kind of enter calendar '21 here and your general thoughts.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot